PHASE 3 TRIAL OF THE TAU AGGREGATION INHIBITOR LEUCO-METHYLTHIONINIUM-BIS (HYDROMETHANESULFONATE) (LMTM) IN MILD TO MODERATE ALZHEIMER'S DISEASESerge Gauthier,Howard Feldman,Lon S. Schneider,Gordon Wilcock,Giovanni B. Frisoni,Jiri Hardlund,Karin A Kook,Damon Wischik,Bjoern Schelter,John M. D. Storey,Charles R. Harrington,Claude M. WischikAlzheimers & Dementia（2016）引用 3|浏览43暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
